Mediators of inflammation in chronic inflammatory bowel disease.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Scandinavian Journal of Gastroenterology, Supplement

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/00365529609094569PMID 8726287
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammatory intermediaries in inflammatory bowel disease

  2005cited by this paper
• Blockade of leukotriene production by a single oral dose of MK‐0591 in active ulcerative colitis

  1995cited by this paper
• A randomized trial of comprehensive geriatric assessment in the care of hospitalized patients.

  1995cited by this paper
• Selective 5‐lipoxygenase inhibition by zileuton in the treatment of relapsing ulcerative colitis: a randomized double‐blind placebo‐controlled multicentre trial

  1994cited by this paper
• Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): a review.

  1994cited by this paper
• Cyclosporin in Crohn's disease. Therapeutic and pathogenetic implications.

  1994cited by this paper
• Thrornboxanes in inflammatory bowel disease—pathogenic and therapeutic implications

  1993cited by this paper
• Review article: thromboxanes in inflammatory bowel disease--pathogenic and therapeutic implications.

  1993cited by this paper
• Immunopharmacology of the gastrointestinal system

  1993cited by this paper
• Octreotide effectively decreases mucosal damage in experimental colitis.

  1993cited by this paper
• Role of reactive oxygen metabolites in inflammatory bowel disease

  1993cited by this paper
• Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis.

  1992cited by this paper
• Inhibitor of interleukin-1 alpha and interleukin-1 beta-induced T-cell activation in serum of patients with active Crohn's disease.

  1991cited by this paper
• Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis.

  1990cited by this paper
• Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis.

  1990cited by this paper
• Interleukins and tumor necrosis factor in inflammation.

  1990cited by this paper
• The role of chemical mediators in the pathogenesis of inflammation with emphasis on the kinin system.

  1990cited by this paper
• Selective 5-lipoxygenase inhibition in ulcerative colitis.

  1990cited by this paper
• The soluble interleukin-2 receptor: biology, function, and clinical application.

  1990cited by this paper
• Eicosanoids and inflammatory bowel disease: regulation and prospects for therapy.

  1990cited by this paper
• Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases.

  1990cited by this paper
• Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid.

  1990cited by this paper
• Enhanced local production of complement components in the small intestines of patients with Crohn's disease.

  1990cited by this paper
• Nitrite from inflammatory cells—A cancer risk factor in ulcerative colitis?

  1990cited by this paper
• Cytokines: coordinators of immune and inflammatory responses.

  1990cited by this paper
• Cytokines and endothelial cell biology.

  1990cited by this paper
• 5-HETE: uptake, distribution, and metabolism in MDCK cells.

  1989cited by this paper
• Interleukins and the immune system 2.

  1989cited by this paper
• The synthesis, catabolism, and pathophysiological role of platelet-activating factor.

  1989cited by this paper
• Neuropeptides and inflammation: the role of substance P.

  1989cited by this paper
• Lymphokines and the intestinal immune response. Role in inflammatory bowel disease.

  1989cited by this paper
• Oxygen radicals: mediators of gastrointestinal pathophysiology.

  1989cited by this paper
• Interleukins and the immune system 1.

  1989cited by this paper
• Kinins as mediators of intestinal secretion.

  1989cited by this paper
• Interleukin-1

  1988cited by this paper
• Chemotactic peptides

  1988cited by this paper
• Neuropeptides, inflammation, and motility

  1988cited by this paper
• Neuroendocrine modulation of the immune system. Possible implications for inflammatory bowel disease.

  1988cited by this paper
• Concanavalin A induced suppressor activity exerted by peripheral blood mononuclear cells--with special reference to chronic inflammatory bowel disease.

  1988cited by this paper
• In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis.

  1988cited by this paper
• Neutrophil-mediated mucosal injury

  1988cited by this paper
• Kinin formation: mechanisms and role in inflammatory disorders.

  1988cited by this paper
• Platelet-activating factor and inflammatory bowel disease.

  1988cited by this paper
• In vitro studies on the significance of arachidonate metabolism and other oxidative processes in the inflammatory response of human neutrophils and macrophages. With special reference to chronic inflammatory bowel disease.

  1988cited by this paper
• Neutrophilic granulocyte function. Quantitative leukocyte mobilization and function of circulating and exudative neutrophils.

  1988cited by this paper
• Alternatives to the acid-oriented approach to ulcer disease: does 'cytoprotection' exist in man? A new classification of antiulcer agents.

  1988cited by this paper
• Incomplete distal denervation and recurrent ulcer after parietal cell vagotomy.

  1988cited by this paper
• For our readers: This month in Gastroenterology

  1988cited by this paper
• Concanavalin A induced suppressor activity exerted by peripheral blood mononuclear cells--with special reference to chronic inflammatory bowel disease.

  1988cited by this paper
• Neutrophilic granulocyte function. Quantitative leukocyte mobilization and function of circulating and exudative neutrophils.

  1988cited by this paper
• Inflammation--histamine and 5-hydroxytryptamine.

  1987cited by this paper
• Lipid mediators produced through the lipoxygenase pathway.

  1987cited by this paper
• The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger

  1987cited by this paper
• Complement-derived peptide mediators of inflammation.

  1987cited by this paper
• In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.

  1987cited by this paper
• Complement and function of neutrophils in chronic inflammatory bowel disease.

  1986cited by this paper
• Platelet activating factor: a biologically active phosphoglyceride.

  1986cited by this paper
• Eicosanoids and their role in the pathogenesis of diarrhoeal diseases.

  1986cited by this paper
• The membrane attack complex of complement.

  1986cited by this paper
• Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis.

  1986cited by this paper
• Arachidonic acid metabolism in human neutrophils: lack of effect of cyclosporine A.

  1986cited by this paper
• Oxygen-derived free radicals in postischemic tissue injury.

  1985cited by this paper
• The role of arachidonic acid oxygenation products in pain and inflammation.

  1984cited by this paper
• Complement and bacteria: chemistry and biology in host defense.

  1984cited by this paper
• Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.

  1984cited by this paper
• Comparison of radioimmunological determinations with gas chromatography mass spectrometry dosage. A study of PGE2 and PGF2alpha in gastrointestinal fluids.

  1983cited by this paper
• Prostaglandin E2 in jejunal fluids and its potential diagnostic value for selecting patients with indomethacin‐sensitive diarrhoea

  1981cited by this paper
• lnterleukin-10-Deficient Mice Develop Chronic Enterocolitis

  year unknowncited by this paper

• The ameliorative effect of Lactiplantibacillus plantarum SCS2 on DSS-induced murine colitis

  2025cites this paper
• Comparative treatment of Sulfasalazine+Ezetimibe combination and Sulfasalazine in a rat model with induced colitis

  2023cites this paper
• Mast cell-mediated immune regulation in health and disease

  2023cites this paper
• Lactobacillus acidophilus and HKL Suspension Alleviates Ulcerative Colitis in Rats by Regulating Gut Microbiota, Suppressing TLR9, and Promoting Metabolism

  2022cites this paper
• The Immune Change of the Lung and Bowel in an Ulcerative Colitis Rat Model and the Protective Effect of Sodium Houttuyfonate Combined With Matrine

  2022cites this paper
• Effects of Gastric Neuromodulation on Crohn's Disease in Patients With Coexisting Symptoms of Gastroparesis

  2020cites this paper
• Study of metabolic alterations in inflammatory bowel diseases

  2020cites this paper
• Biological science

  2020cites this paper
• Microbial metabolite deoxycholic acid controls Clostridium perfringens-induced chicken necrotic enteritis through attenuating inflammatory cyclooxygenase signaling

  2019cites this paper
• A novel antimicrobial alternative of microbiota metabolic product deoxycholic acid controls chicken necrotic enteritis

  2018cites this paper
• Microbial metabolite deoxycholic acid controls Clostridium perfringens-induced chicken necrotic enteritis through attenuating cyclooxygenase signaling

  2018cites this paper
• Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients

  2017cites this paper
• Targeted metabolomics reveals altered oxylipin profiles in plasma of mild cognitive impairment patients

  2017cites this paper
• Complement component 6 deficiency increases susceptibility to dextran sulfate sodium-induced murine colitis.

  2016cites this paper
• RED NACIONAL DE INVESTIGACIÓN EN HEPATOLOGÍA Y GASTROENTEROLOGÍA. RNIHG

  2016cites this paper
• Bacteria-Derived Compatible Solutes Ectoine and 5α-Hydroxyectoine Act as Intestinal Barrier Stabilizers to Ameliorate Experimental Inflammatory Bowel Disease.

  2015cites this paper
• Protective effect of simvastatin and rosuvastatin on trinitrobenzene sulfonic acid-induced colitis in rats

  2015cites this paper
• Protective effect of ginger volatile oil against acetic acid-induced colitis in rats: a light microscopic evaluation.

  2014cites this paper
• Inflammatory pathways of importance for management of inflammatory bowel disease.

  2014cites this paper
• Extraintestinal manifestations of inflammatory bowel disease in children

  2014cites this paper
• [Potential relevance of microRNAs in the diagnostics of inflammatory bowel diseases].

  2014cites this paper
• Protective effect of magnesium lithospermate B against dextran sodiumsulfate induced ulcerative colitis in mice.

  2013cites this paper
• Sesame oil accelerates healing of 2,4,6-trinitrobenzenesulfonic acid-induced acute colitis by attenuating inflammation and fibrosis.

  2013cites this paper
• Novel effects of ectoine, a bacteria-derived natural tetrahydropyrimidine, in experimental colitis.

  2013cites this paper
• MicroRNAs in inflammatory bowel disease--pathogenesis, diagnostics and therapeutics.

  2012cites this paper
• Atividade Antiinflamatória Intestinal da Escopoletina e Fraxetina nas Fases Aguda e Crônica do Processo Inflamatório Induzido por TNBS em Ratos

  2010cites this paper
• THERAPEUTIC EFFECT OF SHI-219, A NOVEL WATER SOLUBLE PRODRUG OF EG626 (PHTALAZINOL), ON MOUSE DEXTRAN SODIUM SULFATE-INDUCED COLITIS

  2008cites this paper
• UNIVERSIDADE ESTADUAL PAULISTA INSTITUTO DE BIOCIÊNCIAS CAMPUS DE BOTUCATU Efeitos sinérgicos da paepalantina, uma isocumarina is olada dos capítulos florais de Paepalanthus bromelioides, sobre a atividade da sulfassalazina no modelo de colite ulcerativa induzida por ácido trinitrobenzenosulfônico e

  2008cites this paper
• The intestinal anti-inflammatory effects of the novel agent UR-1505 in the TNBS model of rat colitis are mediated by T-lymphocyte inhibition.

  2007cites this paper
• Immunoexpression of cyclooxygenase-1 and -2 in ulcerative colitis.

  2007cites this paper
• Increased Potency of a Novel Complement Factor 5a Receptor Antagonist in a Rat Model of Inflammatory Bowel Disease

  2005cites this paper
• [Pathogenesis and immunotherapy in inflammatory bowel disease: lessons from animal models].

  2005cites this paper
• A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitis.

  2005cites this paper
• The diverse actions of nicotine and different extracted fractions from tobacco smoke against hapten-induced colitis in rats.

  2005cites this paper
• Patogenia e inmunoterapia de la enfermedad inflamatoria intestinal: lecciones de los modelos animales

  2005cites this paper
• 51 - Inflammatory Bowel Disease

  2005cites this paper
• Model of Inflammatory Bowel Disease Protects against Disease Pathology in a Rat A Potent Human C5a Receptor Antagonist

  2003cites this paper
• Crohn's Disease

  2003cites this paper
• Upregulation of Interleukin-12 and -17 in Active Inflammatory Bowel Disease

  2003cites this paper
• A Potent Human C5a Receptor Antagonist Protects against Disease Pathology in a Rat Model of Inflammatory Bowel Disease 1

  2003cites this paper
• Effect of pharmacologically induced smooth muscle activation on permeability in murine colitis.

  2003cites this paper
• Delineation of the protective action of zinc sulfate on ulcerative colitis in rats.

  2002cites this paper
• Effects of Topical Ropivacaine on Eicosanoids and Neurotransmitters in the Rectum of Patients with Distal Ulcerative Colitis

  2002cites this paper
• Spatial heterogeneity of TNF-alpha-induced T cell migration to colonic mucosa is mediated by MAdCAM-1 and VCAM-1.

  2002cites this paper
• Expression of 5-lipoxygenase mRNA is unchanged in the colon of patients with active inflammatory bowel disease

  2002cites this paper
• Suppression of dextran sulfate sodium-induced colitis in kininogen-deficient rats and non-peptide B2 receptor antagonist-treated rats.

  2002cites this paper
• In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production.

  2001cites this paper
• Increased Serum Levels of Eotaxin in Patients with Inflammatory Bowel Disease

  2001cites this paper
• Nutrient Considerations in Inflammatory Bowel Disease and Short Bowel Syndrome

  2001cites this paper
• Leukotrienes as targets in the gut

  2001cites this paper
• The Effect of Dexamethasone Treatment on Murine Colitis

  2000influential citation
• The effect of dexamethasone treatment on murine colitis.

  2000cites this paper
• Systemic inflammatory responses during laparoscopic and open inguinal hernia repair: a randomised prospective study.

  2000cites this paper
• Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper

  2000cites this paper
• Neuroendocrine changes in colon of mice with a disrupted IL‐2 gene

  2000cites this paper
• Dietary fat, immunity and inflammatory disease.

  2000cites this paper
• Review article: the potential role of nitric oxide in chronic inflammatory bowel disorders

  1999cites this paper
• Immune markers for monitoring the progression of autoimmune disease

  1999cites this paper
• Experimental Colitis Induced by Trinitrobenzenesulfonic Acid (An Ultrastructural and Histochemical Study)

  1999cites this paper
• Coincidence of hereditary angioedema (HAE) with Crohn's disease.

  1999cites this paper
• Chronic gastrointestinal inflammation.

  1999cites this paper
• Antioxidant defense in erythrocytes and plasma of patients with active and quiescent Crohn disease and ulcerative colitis: a chemiluminescent study.

  1999cites this paper
• Expression of lymphocyte-endothelial receptor-ligand pairs, α4β7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease

  1999cites this paper
• Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha.

  1998cites this paper
• Neuropeptides: mediators of inflammation and tissue repair?

  1998cites this paper
• Antioxidant activity of 5-aminosalicylic acid against lipid peroxidation in the presence of vitamins C and E

  1998cites this paper
• Inflammatory bowel diseases: a new wave of therapy

  1998cites this paper
• Transient alteration in intestinal permeability to technetium Tc99m diethylenetriaminopentaacetate during the prodromal stages of alimentary laminitis in ponies.

  1998cites this paper
• The Circulating Common Gamma Chain (CD132) in Inflammatory Bowel Disease

  1998cites this paper
• Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.

  1998cites this paper
• Soluble mediators and the interaction of drugs in IBD.

  1998cites this paper
• From basic science to future medical options for treatment of ulcerative colitis.

  1997cites this paper
• Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease.

  1997cites this paper
• Direct morphological evidence of neuroimmunomodulation in colonic mucosa of patients with Crohn's disease.

  1997cites this paper
• Extraintestinal manifestations of inflammatory bowel disease in children.

  1994cites this paper